These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22002792)

  • 1. Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms.
    Wongkitisophon P; Chanprapaph K; Rattanakaemakorn P; Vachiramon V
    Acta Derm Venereol; 2012 Mar; 92(2):200-5. PubMed ID: 22002792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases.
    Chen YC; Chiu HC; Chu CY
    Arch Dermatol; 2010 Dec; 146(12):1373-9. PubMed ID: 20713773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DRESS syndrome: the great clinical mimicker.
    Fleming P; Marik PE
    Pharmacotherapy; 2011 Mar; 31(3):332. PubMed ID: 21361742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
    Oelze LL; Pillow MT
    J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug reaction with eosinophilia and systemic symptoms (DRESS)].
    Descamps V
    Rev Prat; 2012 Dec; 62(10):1347-52. PubMed ID: 23424909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
    Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
    Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone.
    Natkunarajah J; Goolamali S; Craythorne E; Benton E; Smith C; Morris-Jones R; Wendon J; Higgins E; Creamer D
    Eur J Dermatol; 2011; 21(3):385-91. PubMed ID: 21527371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DRESS syndrome: a literature review.
    Cacoub P; Musette P; Descamps V; Meyer O; Speirs C; Finzi L; Roujeau JC
    Am J Med; 2011 Jul; 124(7):588-97. PubMed ID: 21592453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
    Bourezane Y; Salard D; Hoen B; Vandel S; Drobacheff C; Laurent R
    Clin Infect Dis; 1998 Nov; 27(5):1321-2. PubMed ID: 9827291
    [No Abstract]   [Full Text] [Related]  

  • 10. Patch testing is an effective method for the diagnosis of carbamazepine-induced drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome in an 8-year-old girl.
    Buyuktiryaki AB; Bezirganoglu H; Sahiner UM; Yavuz ST; Tuncer A; Kara A; Sackesen C
    Australas J Dermatol; 2012 Nov; 53(4):274-7. PubMed ID: 22524313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DRESS syndrome associated with carbamazepine and phenytoin.
    Allam JP; Paus T; Reichel C; Bieber T; Novak N
    Eur J Dermatol; 2004; 14(5):339-42. PubMed ID: 15358574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.
    Walsh S; Diaz-Cano S; Higgins E; Morris-Jones R; Bashir S; Bernal W; Creamer D
    Br J Dermatol; 2013 Feb; 168(2):391-401. PubMed ID: 23034060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG).
    Fields KS; Petersen MJ; Chiao E; Tristani-Firouzi P
    J Drugs Dermatol; 2005; 4(4):510-3. PubMed ID: 16004028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan.
    Chiou CC; Yang LC; Hung SI; Chang YC; Kuo TT; Ho HC; Hu S; Hong HS; Chung WH
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1044-9. PubMed ID: 18627428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
    D'Orazio JL
    Clin Toxicol (Phila); 2008 Dec; 46(10):1093-4. PubMed ID: 18821094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DRESS syndrome: 11 case reports and a literature review].
    Chaabane A; Aouam K; Ben Fredj N; A Boughattas N
    Therapie; 2010; 65(6):543-50. PubMed ID: 21176761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Ding WY; Lee CK; Choon SE
    Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug rash with eosinophilia and systemic symptoms syndrome associated with use of phenytoin, divalproex sodium, and phenobarbital.
    Brizendine CE; Naik PJ
    Am J Health Syst Pharm; 2013 Mar; 70(6):507-10. PubMed ID: 23456403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.
    Lanzafame M; Rovere P; De Checchi G; Trevenzoli M; Turazzini M; Parrinello A
    Scand J Infect Dis; 2001; 33(6):475-6. PubMed ID: 11450872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DRESS syndrome].
    Khaled A; Souissi A; Zeglaoui F; El Fekih N; Daghfous R; Fazaa B
    Tunis Med; 2012 Oct; 90(10):749-51. PubMed ID: 23096521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.